Recurrent implantation failure: why cycles fail and what to change

What is Recurrent Implantation Failure (RIF)?

Experiencing a negative pregnancy test after an IVF cycle is emotionally devastating. When failure repeats across 2, 3, or more embryo transfers, couples are often told "it was just bad luck" or pushed directly toward third-party donor options without an in-depth clinical explanation.

Recurrent Implantation Failure is not a final dead-end; it is a clinical symptom requiring methodical investigation. Successful implantation requires three synchronized pillars: 1. A chromosomally competent, viable blastocyst. 2. A receptive, sterile, and hormonally primed endometrium. 3. Optimal embryonic transfer technique with zero trauma to the uterine cavity.

Pillar 1: The Embryo Factor (70% of Failures)

Even embryos that appear visually "Grade 4AA" under basic light microscopy can harbor severe chromosomal aneuploidies (abnormal chromosome counts) that cause natural developmental arrest shortly after uterine transfer.

• Day-3 vs Day-5 Culture: If previous clinics transferred Day-3 cleavage-stage embryos (6–8 cells), many of those embryos were destined to arrest naturally prior to genome activation on Day 4. Culturing to Day-5 blastocyst stage filters out 50% of non-viable embryos before transfer.
• Laboratory Quality Variables: Subtle volatile organic compounds (VOCs) in laboratory air, shared box incubators where doors open 30 times a day, or manual centrifuge friction during sperm preparation damage embryonic cellular spindles.
• Paternal DNA Integrity: Elevated Sperm DNA Fragmentation Index (>30%) causes post-fertilization genomic collapse.

Pillar 2: The Uterine Factor (30% of Failures)

When high-grade, genetically screened blastocysts fail to implant, the uterine environment requires rigorous evaluation:

• Chronic Endometritis (CE): A persistent, asymptomatic bacterial inflammation of the uterine lining (diagnosed via CD138 plasma cell immunohistochemistry on endometrial biopsy). Affects up to 30% of RIF patients and is curable with targeted antibiotic therapy.
• Endometrial Window of Implantation: In approximately 20% of women, the receptive window is displaced (pre-receptive or post-receptive), requiring personalized progesterone timing adjustments.
• Subclinical Uterine Cavity Pathology: Small endometrial polyps, submucosal fibroids, or a thin uterine septum diagnosed and corrected via gentle office hysteroscopy.